Slater Technology Fund is a US-based venture capital firm that focuses on seed and early-stage investments in the life sciences and information technology sectors. The firm primarily supports new venture development in Rhode Island, investing in transformative technology ventures. Typical investment rounds include seed and Series A stages, with investment sizes varying across different portfolio companies.

Notable portfolio companies include Medrobotics, which has raised $11.6 million, Nabsys with $4 million, and Gila Therapeutics with $3 million. Key partners and decision-makers at Slater bring extensive experience in fostering innovation and growth. The firm offers unique value-add services to its portfolio companies, leveraging its not-for-profit status to provide strategic support aimed at achieving transformational impact in their respective industries.

Concentration shown as share of disclosed investments by stage.